The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letters to the EditorFull Access

Distinguishing Between Physiological Dependence and Substance Use Disorder: Response to Ruan et al.

To the Editor: We thank Dr. Ruan and colleagues for their interest in our article (1). They raise two important issues. First, they point out that the terminology used to refer to substance use disorders is inconsistent, particularly when referring to opioids. We agree. We have previously addressed differences between nonmedical opioid use and opioid use disorder, including trends (2), correlates (3), and relationships between them (4).

We also agree that clinicians, researchers, and policy makers often mistakenly conflate the concepts of physiological dependence, which includes tolerance and withdrawal, and substance use disorder. We are pleased to see this key distinction being taken seriously by medical specialties beyond psychiatry. We hope that this will contribute to improved assessment and treatment of patients with pain, reduced risk of nonmedical opioid use, and a lower incidence of opioid use disorder. To minimize confusion, we chose in our article to use DSM-IV criteria, which was the official classification system when the data were collected.

The second issue raised by Dr. Ruan and colleagues is whether use of DSM-IV, rather than DSM-5, compromises our results. Clinical and epidemiological samples have demonstrated a high degree of concordance between DSM-IV and DSM-5 opioid use disorder diagnoses (5, 6). The robustness of our analyses to analytic method suggests that the results are unlikely to be sensitive to these changes in nomenclature. We are not aware of nationally representative samples that have been longitudinally evaluated to assess the relationship between pain and prescription opioid use disorder using DSM-5 criteria. We agree with Dr. Ruan and colleagues that, given the importance of this topic, such a study would be an important contribution.

From the Division of Epidemiology, Services, and Prevention Research, NIDA, Bethesda, Md.; the Department of Psychiatry, New York State Psychiatric Institute and Columbia University, New York; and the Department of Psychiatry, Fundación Jiménez-Díaz, Madrid.

The authors’ disclosures accompany the original article.

References

1 Blanco C, Wall MM, Okuda M, et al.: Pain as a predictor of opioid use disorder in a nationally representative sample. Am J Psychiatry 2016; 173:1189–1195LinkGoogle Scholar

2 Blanco C, Alderson D, Ogburn E, et al.: Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991–1992 and 2001–2002. Drug Alcohol Depend 2007; 90:252–260Crossref, MedlineGoogle Scholar

3 Martins SS, Fenton MC, Keyes KM, et al.: Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychol Med 2012; 42:1261–1272Crossref, MedlineGoogle Scholar

4 Blanco C, Rafful C, Wall MM, et al.: The latent structure and predictors of non-medical prescription drug use and prescription drug use disorders: a national study. Drug Alcohol Depend 2013; 133:473–479Crossref, MedlineGoogle Scholar

5 Boscarino JA, Rukstalis MR, Hoffman SN, et al.: Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria. J Addict Dis 2011; 30:185–194Crossref, MedlineGoogle Scholar

6 Goldstein RB, Chou SP, Smith SM, et al.: Nosologic comparisons of DSM-IV and DSM-5 alcohol and drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions–III. J Stud Alcohol Drugs 2015; 76:378–388Crossref, MedlineGoogle Scholar